Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human AKR1B1 Stable Cell Line

    [CAT#: S01YF-1023-PY146]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;HCT116
    Target Classification
    Kinase Cell Lines
    Target Research Area
    CNS Research
    Related Diseases
    Diabetic Neuropathy; Diabetic Cataract
    Gene ID
    Human:231
    UniProt ID
    Human:P15121

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    AKR1B1, also known as aldose reductase, has various applications in different fields. In the context of cardiac health, AKR1B1 is involved in protecting cardiomyocytes against oxidative stress during open heart surgery. It is activated by cardioplegic solutions, such as Del Nido, and induces the expression of antioxidant and detoxification genes. In bovine females, AKR1B1 is associated with the uterine luteolytic cascade, specifically in the synthesis of prostaglandin F2α. In breast cancer, AKR1B1 is regulated by the p53 tumor suppressor and is implicated in metastasis promotion. In gastric cancer, AKR1B1 is overexpressed and indicates poor prognosis. It regulates the AKT-mTOR pathway, contributing to cancer progression. Additionally, AKR1B1 is involved in the antifungal mechanism of Cinnamomum cassia essential oil against Candida albicans, and its functional components have been identified. Overall, AKR1B1 plays diverse roles in different biological processes and diseases.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human AKR1B1 Stable Cell Line (S01YF-1023-PY146). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Casey Brown (Verified Customer)

    Is AKR1B1 a significant biomarker in ovarian cancer? Feb 13 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Yes, AKR1B1 is involved in the pathogenesis of high-grade serous ovarian cancer and can serve as a potential prognostic biomarker. Feb 13 2022

    chat Casey Miller (Verified Customer)

    How does AKR1B1 contribute to drug resistance in lung cancer? Mar 10 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    AKR1B1 enhances glutathione synthesis, leading to resistance to EGFR-targeted therapy in lung cancer, and its inhibition can restore drug sensitivity. Mar 10 2021

    Published Data

    Fig.1 Knockdown or overexpression AKR1B10 in HCT116 cell lines.

    A Western blot analysis successfully validated the effective suppression of AKR1B1 (using shB1 Clone 1 and shB1 Clone 2) and the introduction of exogenous AKR1B10 in HCT-116 cells. Statistical analysis revealed highly significant differences with ****p < 0.0001 and **p < 0.01, indicating the robustness of the observed outcomes.

    Ref: Taskoparan, Betul, et al. "Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer." Cellular Oncology 40 (2017): 563-578.

    Pubmed: 28929377

    DOI: 10.1007/s13402-017-0351-7

    Research Highlights

    Diao, Hongting. et al. "Del Nido Cardioplegia or Potassium Induces Nrf2 and Protects Cardiomyocytes Against Oxidative Stress." American journal of physiology. Cell physiology, 2023.
    Open heart surgery is a common treatment for coronary artery disease and is often necessary. However, the procedure can lead to reperfusion injury, which can impact cardiac performance and long-term outcomes. The authors examined whether the use of cardioplegia during cardiopulmonary bypass surgery activated Nrf2, a transcription factor that regulates antioxidant and detoxification genes. They found that commonly used cardioplegic solutions, such as High K+/Plegisol, led to activation of Nrf2 and resulted in significant improvements in postoperative cardiac function.
    Diao, Hongting. et al. "Del Nido Cardioplegia or Potassium Induces Nrf2 and Protects Cardiomyocytes Against Oxidative Stress." American journal of physiology. Cell physiology, 2023.
    Pubmed: 37842750   DOI: 10.1152/ajpcell.00436.2022

    Feltrin, Isabella Rio, et al. "Effects of 17β-estradiol on the uterine luteolytic cascade in bovine females at the end of diestrus." Theriogenology (2023).
    In a study involving Nelore heifers, the impact of 17β-estradiol (E2) treatment on day 15 of the estrous cycle was investigated with regard to genes involved in the synthesis of prostaglandin F2α (PGF2α). The heifers underwent hormonal synchronization, and their corpus luteum (CL) area, blood perfusion, and progesterone (P4) plasma levels were monitored. On day 15, they were divided into a Control group and an Estradiol group. The Estradiol group exhibited significantly higher PGFM concentrations at 6 and 7 hours after treatment, indicating an accelerated luteolysis process. Notably, E2 treatment upregulated PGR and OXTR within 3 hours, providing novel insights into cattle luteolysis triggered by E2.
    Feltrin, Isabella Rio, et al. "Effects of 17β-estradiol on the uterine luteolytic cascade in bovine females at the end of diestrus." Theriogenology (2023).
    Pubmed: 37783065   DOI: 10.1016/j.theriogenology.2023.09.019

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare